Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Differential requirements for Smarca5 expression during hematopoietic stem cell commitment

T. Turkova, J. Kokavec, T. Zikmund, N. Dibus, K. Pimkova, D. Nemec, M. Holeckova, L. Ruskova, R. Sedlacek, L. Cermak, T. Stopka

. 2024 ; 7 (1) : 244. [pub] 20240229

Language English Country England, Great Britain

Document type Journal Article

Grant support
24-10435S, 24-10353S Grantová Agentura České Republiky (Grant Agency of the Czech Republic)
NU21-08-00312, NU22-05-00374 Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
LX22NPO5102, SVV 260637, UNCE/MED/016, COOPERATIO Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
CZ.02.1.01/0.0/0.0/16_013/0001789, CZ.02.1.01/0.0/0.0/18_046/0015861 Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)

The formation of hematopoietic cells relies on the chromatin remodeling activities of ISWI ATPase SMARCA5 (SNF2H) and its complexes. The Smarca5 null and conditional alleles have been used to study its functions in embryonic and organ development in mice. These mouse model phenotypes vary from embryonic lethality of constitutive knockout to less severe phenotypes observed in tissue-specific Smarca5 deletions, e.g., in the hematopoietic system. Here we show that, in a gene dosage-dependent manner, the hypomorphic allele of SMARCA5 (S5tg) can rescue not only the developmental arrest in hematopoiesis in the hCD2iCre model but also the lethal phenotypes associated with constitutive Smarca5 deletion or Vav1iCre-driven conditional knockout in hematopoietic progenitor cells. Interestingly, the latter model also provided evidence for the role of SMARCA5 expression level in hematopoietic stem cells, as the Vav1iCre S5tg animals accumulate stem and progenitor cells. Furthermore, their hematopoietic stem cells exhibited impaired lymphoid lineage entry and differentiation. This observation contrasts with the myeloid lineage which is developing without significant disturbances. Our findings indicate that animals with low expression of SMARCA5 exhibit normal embryonic development with altered lymphoid entry within the hematopoietic stem cell compartment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007031
003      
CZ-PrNML
005      
20240423155654.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s42003-024-05917-z $2 doi
035    __
$a (PubMed)38424235
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Turkova, Tereza $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000253291812
245    10
$a Differential requirements for Smarca5 expression during hematopoietic stem cell commitment / $c T. Turkova, J. Kokavec, T. Zikmund, N. Dibus, K. Pimkova, D. Nemec, M. Holeckova, L. Ruskova, R. Sedlacek, L. Cermak, T. Stopka
520    9_
$a The formation of hematopoietic cells relies on the chromatin remodeling activities of ISWI ATPase SMARCA5 (SNF2H) and its complexes. The Smarca5 null and conditional alleles have been used to study its functions in embryonic and organ development in mice. These mouse model phenotypes vary from embryonic lethality of constitutive knockout to less severe phenotypes observed in tissue-specific Smarca5 deletions, e.g., in the hematopoietic system. Here we show that, in a gene dosage-dependent manner, the hypomorphic allele of SMARCA5 (S5tg) can rescue not only the developmental arrest in hematopoiesis in the hCD2iCre model but also the lethal phenotypes associated with constitutive Smarca5 deletion or Vav1iCre-driven conditional knockout in hematopoietic progenitor cells. Interestingly, the latter model also provided evidence for the role of SMARCA5 expression level in hematopoietic stem cells, as the Vav1iCre S5tg animals accumulate stem and progenitor cells. Furthermore, their hematopoietic stem cells exhibited impaired lymphoid lineage entry and differentiation. This observation contrasts with the myeloid lineage which is developing without significant disturbances. Our findings indicate that animals with low expression of SMARCA5 exhibit normal embryonic development with altered lymphoid entry within the hematopoietic stem cell compartment.
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    12
$a hematopoetické kmenové buňky $x metabolismus $7 D006412
650    12
$a hematopoéza $x genetika $7 D006410
650    _2
$a buněčná diferenciace $x genetika $7 D002454
650    _2
$a adenosintrifosfatasy $x metabolismus $7 D000251
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kokavec, Juraj $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000302674570
700    1_
$a Zikmund, Tomas $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000324523749
700    1_
$a Dibus, Nikol $u Laboratory of Cancer Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/000000032743352X
700    1_
$a Pimkova, Kristyna $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000280333651
700    1_
$a Nemec, Dusan $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic $1 https://orcid.org/0009000436249745
700    1_
$a Holeckova, Marketa $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic
700    1_
$a Ruskova, Livia $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic
700    1_
$a Sedlacek, Radislav $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic $1 https://orcid.org/000000023352392X $7 xx0140532
700    1_
$a Cermak, Lukas $u Laboratory of Cancer Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic. lukas.cermak@img.cas.cz $1 https://orcid.org/0000000287773692 $7 xx0140314
700    1_
$a Stopka, Tomas $u Hematology Laboratories, BIOCEV; 1st Faculty of Medicine, Charles University, Vestec, Czech Republic. tstopka@lf1.cuni.cz $1 https://orcid.org/0000000172366894 $7 xx0101300
773    0_
$w MED00197237 $t Communications biology $x 2399-3642 $g Roč. 7, č. 1 (2024), s. 244
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38424235 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155650 $b ABA008
999    __
$a ok $b bmc $g 2081188 $s 1216798
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 7 $c 1 $d 244 $e 20240229 $i 2399-3642 $m Communications biology $n Commun Biol $x MED00197237
GRA    __
$a 24-10435S, 24-10353S $p Grantová Agentura České Republiky (Grant Agency of the Czech Republic)
GRA    __
$a NU21-08-00312, NU22-05-00374 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
GRA    __
$a LX22NPO5102, SVV 260637, UNCE/MED/016, COOPERATIO $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
GRA    __
$a CZ.02.1.01/0.0/0.0/16_013/0001789, CZ.02.1.01/0.0/0.0/18_046/0015861 $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...